Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The 2004 World Health Organization classification of lung tumors.

Literature DB >> 15898407

The 2004 World Health Organization classification of lung tumors.

Mary Beth Beasley¹, Elisabeth Brambilla, William D Travis.

Abstract

Entities: Disease

Mesh：

Year: 2005 PMID： 15898407 DOI： 10.1053/j.ro.2005.01.001

Source DB: PubMed Journal: Semin Roentgenol ISSN： 0037-198X Impact factor: 0.800

Keyword Cloud
Cited

× No keyword cloud information.

193 in total

1. Bronchopulmonary carcinoid tumors.

Authors: Christopher Cao; Tristan D Yan
Journal: J Thorac Dis Date: 2010-03 Impact factor: 2.895

2. IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance.

Authors: Xueyan Zhang; Jiayuan Sun; Huimin Wang; Yuqing Lou; Yanwei Zhang; Huifang Sha; Jiuxian Feng; Baohui Han
Journal: Tumour Biol Date: 2013-08-29

Review 3. Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.

Authors: Roberto E Favoni; Antonio Daga; Paolo Malatesta; Tullio Florio
Journal: Br J Pharmacol Date: 2012-05 Impact factor: 8.739

4. Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib.

Authors: Stephanie Heon; Beow Y Yeap; Gregory J Britt; Daniel B Costa; Michael S Rabin; David M Jackman; Bruce E Johnson
Journal: Clin Cancer Res Date: 2010-10-28 Impact factor: 12.531

5. Principles of biopsy in suspected lung cancer: priority still based on invasion in the era of targeted therapy?

Authors: Hua-Jun Chen; Jin-Ji Yang; Chong-Rui Xu; Yuan-Yuan Lei; Dong-Lan Luo; Hong-Hong Yan; Yi-Long Wu
Journal: J Thorac Dis Date: 2013-06 Impact factor: 2.895

6. VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy.

Authors: Erick Riquelme; Milind Suraokar; Carmen Behrens; Heather Y Lin; Luc Girard; Monique B Nilsson; George Simon; Jing Wang; Kevin R Coombes; J Jack Lee; Waun Ki Hong; John Heymach; John D Minna; Ignacio I Wistuba
Journal: Clin Cancer Res Date: 2014-05-21 Impact factor: 12.531

The 2004 World Health Organization classification of lung tumors.

1. Bronchopulmonary carcinoid tumors.

2. IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance.

Review 3. Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.

4. Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib.

5. Principles of biopsy in suspected lung cancer: priority still based on invasion in the era of targeted therapy?

6. VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy.

Review 7. Progress in the management of limited-stage small cell lung cancer.

8. Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.

9. Differential expression of inflammasomes in lung cancer cell lines and tissues.

10. The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma.